After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Terns Pharmaceuticals Inc is $2.48B. A total of 5.33 million shares were traded on the day, compared to an average of 2.38M shares.
In the most recent transaction, Quigley Jill M. sold 24,520 shares of TERN for 18.00 per share on Nov 04 ’25. After the transaction, the Director now owns 0 company shares. In a previous transaction on Nov 04 ’25, JILL QUIGLEY bought 24,520 shares at 14.03 per share.
Among the insiders who sold shares, Kuriakose Emil disposed of 944 shares on Oct 01 ’25 at a per-share price of $7.85. This resulted in the Chief Medical Officer holding 51,520 shares of TERN after the transaction. In another insider transaction, Kuriakose Emil sold 853 shares at $4.27 per share on Jul 01 ’25. Company shares held by the Chief Medical Officer now total 52,464.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, TERN has a high of $26.12 and a low of $1.87.
As of this writing, TERN has an earnings estimate of -$0.31 per share for the current quarter. EPS was calculated based on a consensus of 7.0 estimates, with a high estimate of -$0.29 per share and a lower estimate of -$0.33. The company reported an EPS of -$0.24 in the last quarter
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. TERN’s latest balance sheet shows that the firm has $165.98M in Cash & Short Term Investments as of fiscal 2021. There were $0.00 in debt and $6.82M in liabilities at the time. Its Book Value Per Share was $3.25, while its Total Shareholder’s Equity was $160.30M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for TERN is Buy with a score of 4.83.
